Polycystic Ovary Syndrome - PowerPoint PPT Presentation

1 / 29
About This Presentation
Title:

Polycystic Ovary Syndrome

Description:

... Calpain-5 Calpain-10 Signs and Symptoms Pre-puberty Increased levels of adrenal androgen Increased insulin levels Ovarian hyperandrogenism Leads to ... – PowerPoint PPT presentation

Number of Views:1668
Avg rating:3.0/5.0
Slides: 30
Provided by: fpmEmoryE
Learn more at: https://med.emory.edu
Category:

less

Transcript and Presenter's Notes

Title: Polycystic Ovary Syndrome


1
Polycystic Ovary Syndrome
  • Lianne Beck, MD
  • Assistant Professor
  • Emory Family Medicine

2
Overview
  • Prevalence and Pathogenesis
  • Signs and Symptoms
  • Diagnosis
  • Treatment

3
Background
  • Stein Leventhal 1935
  • Amenorrhea
  • Infertility
  • Hirsutism
  • Enlarged polycystic ovaries

4
Prevalence
  • Most common hormonal and reproductive problem
    affecting women of child-bearing age
  • Present in 5-10 of women
  • Commonly under-diagnosed due to use of birth
    control pills

5
Pathogenesis
  • UNKNOWN
  • High insulin levels
  • High androgen levels
  • High LH
  • Low estro/prog

6
Pathogenesis
  • Genetics
  • Insulin-receptor substrate (IRS-1,IRS-2)
  • Calpain-5
  • Calpain-10

7
Signs and Symptoms
  • Pre-puberty
  • Increased levels of adrenal androgen
  • Increased insulin levels
  • Ovarian hyperandrogenism
  • Leads to precocious puberty

8
Signs and Symptoms
  • Adolescence and Adulthood
  • Anovulation
  • Hyperandrogenism
  • Polycystic ovaries
  • Obesity-50 of women
  • Leads to reproductive disorders

9
Signs and Symptoms
  • Late Adulthood
  • Diabetes
  • Hypertension
  • Dyslipidemia
  • Cardiovascular disease
  • Leads to metabolic effects

10
Other Complications
  • Endometrial Cancer
  • Breast Cancer

11
Clinical Features
  • Acne
  • Hirsutism

12
Clinical Features
  • Acanthosis nigricans
  • Skin tags

13
Clinical Features
  • Male-pattern alopecia
  • Central obesity

14
Diagnostic Criteria
  • 1990 NIH criteria (all 3 must be met)
  • Hyperandrogenism, either clinical or biochemical
  • Menstrual irregularity (oligo- or anovulation)
  • Exclusion of other causes
  • Prolactinoma
  • Thyroid disease
  • Virilizing tumors of adrenal or ovarian tumors
  • Congenital adrenal hyperplasia
  • Cushing's syndrome

15
Revised Diagnostic Criteria
  • 2003 Rotterdam Criteria
  • Presence of at least two of the following
  • Oligo/anovulation
  • Hyperandrogenism
  • Polycystic ovaries on ultrasound
  • And the exclusion of other causes

16
PCOS and Associated Lab Findings
  • Laboratory tests
  • Elevated androgen (i.e., testosterone) levels
  • Elevated LH with normal to mildly elevated FSH
    level
  • Insulin resistance with hyperinsulinemia
  • Glucose intolerance
  • Hyperlipidemia
  • Ultrasound findings
  • Multiple (nine or more) subcortical follicular
    cysts
  • Increased ovarian stromal density and/or volume

17
Sonogram of PCOS
The sonogram has a compact enlarged central
stroma surrounded by multiple ( 12 or more) small
cysts, of 2 to 9 mm in size.
18
Suggested Work-up of PCOS
  • Urine HCG
  • Prolactin level
  • TSH
  • Testosterone
  • LH/FSH (31)
  • Fasting insulin
  • Fasting glucose, 2 hr GTT
  • Fasting lipids
  • Pelvic US
  • DHEAS
  • 17-OHP
  • Dexamethasone suppression test
  • Endometrial biopsy

--Suggested only in selected patients.
19
Goals of Treatment
  • Decrease hyperinsulinism
  • Decrease hyperandrogenism
  • Induce ovulation
  • Prevent endometrial hyperplasia
  • Prevent metabolic complications
  • Weight loss

20
Behavior Modification
  • Weight reduction
  • Diet and exercise
  • Decreases serum androgen, insulin and LH levels
    and improves lipid abnormalities

21
First-Line Medications
22
Second-Line Medications
23
Patient Support
  • www.soulcysters.com
  • www.pcos.meetup.com
  • www.pcosupport.org

24
(No Transcript)
25
(No Transcript)
26
Quiz
  • Which one of the following drugs occasionally
    used to treat hirsutism in polycystic ovary
    syndrome (PCOS) is U.S Food and Drug
    Administration pregnancy category X?
  • A. Spironolactone (Aldactone)
  • B. Metformin (Glucophage)
  • C. Finasteride (Propecia)
  • D. Flutamide (formerly Eulexin)

27
  • Which one of the following drugs has the most
    data supporting its effectiveness in treating
    most manifestations of PCOS?
  • A. Rosiglitazone (Avandia)
  • B. Metformin
  • C. Clomiphene (Clomid)
  • D. Spironolactone

28
Questions?
29
References
  • American Journal of Gynecology. 1998. Dec179 (6
    Pt 2) S101
  • Hunter MH. Sterrit JJ. Am Fam Phys 2000, vol. 62,
    no. 5
  • Norman RJ. Wu R. Stankiewicz MT. Polycystic Ovary
    Syndrome. MJA 2004 180 (3) 132-137.
  • Marrinan G. Stein M. Polycystic Ovarian Disease
    (Stein-Leventhal Syndrome. E-Medicine, May 24,
    2005.
  • Radosh L. Drug Treatments for Polycystic Ovarian
    Syndrome. Am Fam Phys 2009, vol. 79, no. 8
Write a Comment
User Comments (0)
About PowerShow.com